semaglutide cause insomnia Top 5 Common Side Effects and How to Minimize Them Do Weight Loss Injections Affect

recently presented detailed Phase 2b results for berobenatide (PF3944), an investigational once-weekly and once-monthly GLP-1 receptor agonist, showing proof of concept for meaningful weight loss with low gastrointestinal side effects across obesity and type 2 diabetes populations

This systematic review and meta-analysis evaluated the effects of oral semaglutide, compared with placebo, on cardiometabolic risk factors in overweight and obese adults with or without diabetes

The rapidly evolving landscape for CKD-protective therapies in type 2 diabetes currently includes sodium-glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1 RA), both of which demonstrate cardiorenal outcome benefits

Semaglutide can support modest weight loss goals like 15 pounds, but outcomes depend on starting dose, treatment duration, lifestyle factors, and individual genetic predispositions in GLP-1 receptor pathways

To date, few immediate allergic reactions due to GLP-1 receptor agonists were reported

GLP-1 drugs cause rapid weight loss, which for some users comes with unexpected and less desirable side effects, such as an altered sense of smell and taste, sagging skin, wrinkles, muscle mass loss, and bad breath